Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.

autoimmunity drug delivery exosomes extracellular vesicles microparticles systemic lupus erythematosus therapy

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
22 Dec 2020
Historique:
received: 28 11 2020
revised: 17 12 2020
accepted: 18 12 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 31 12 2020
Statut: epublish

Résumé

Exosomes, nanometer-sized lipid-bilayer-enclosed extracellular vesicles (EVs), have attracted increasing attention due to their inherent ability to shuttle proteins, lipids and genes between cells and their natural affinity to target cells. Their intrinsic features such as stability, biocompatibility, low immunogenicity and ability to overcome biological barriers, have prompted interest in using exosomes as drug delivery vehicles, especially for gene therapy. Evidence indicates that exosomes play roles in both immune stimulation and tolerance, regulating immune signaling and inflammation. To date, exosome-based nanocarriers delivering small molecule drugs have been developed to treat many prevalent autoimmune diseases. This review highlights the key features of exosomes as drug delivery vehicles, such as therapeutic cargo, use of targeting peptide, loading method and administration route with a broad focus. In addition, we outline the current state of evidence in the field of exosome-based drug delivery systems in systemic lupus erythematosus (SLE), evaluating exosomes derived from various cell types and engineered exosomes.

Identifiants

pubmed: 33374908
pii: pharmaceutics13010003
doi: 10.3390/pharmaceutics13010003
pmc: PMC7821934
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI18/01405
Organisme : Instituto de Salud Carlos III
ID : CD18/00166, Sara Borrell

Références

Nat Rev Rheumatol. 2020 Oct;16(10):565-579
pubmed: 32884126
Cytotechnology. 2016 Oct;68(5):2125-38
pubmed: 26856590
Cell Transplant. 2013;22(12):2267-77
pubmed: 24388428
Int J Oncol. 2019 May;54(5):1719-1733
pubmed: 30864689
Mol Pharm. 2020 May 4;17(5):1723-1733
pubmed: 32233440
Front Immunol. 2014 Nov 04;5:556
pubmed: 25414703
Drug Deliv. 2018 Nov;25(1):241-255
pubmed: 29334272
PLoS One. 2015 Nov 03;10(11):e0141860
pubmed: 26529317
Blood. 2012 Jan 19;119(3):756-66
pubmed: 22031862
AAPS J. 2017 Nov;19(6):1691-1702
pubmed: 29047044
Pharmaceutics. 2018 Nov 06;10(4):
pubmed: 30404188
Gene. 2020 Aug 15;751:144764
pubmed: 32428694
Biomed Pharmacother. 2016 Oct;83:1154-1163
pubmed: 27551763
Pharmaceuticals (Basel). 2020 Aug 04;13(8):
pubmed: 32759810
J Control Release. 2018 Oct 10;287:156-166
pubmed: 30165139
Bioconjug Chem. 2014 Oct 15;25(10):1777-84
pubmed: 25220352
J Mater Chem B. 2019 Apr 21;7(15):2421-2433
pubmed: 32255119
Pharmaceutics. 2020 Jul 26;12(8):
pubmed: 32722622
Mol Pharm. 2015 Oct 5;12(10):3650-7
pubmed: 26376343
Biomaterials. 2018 Sep;178:302-316
pubmed: 29982104
Cells. 2020 Aug 21;9(9):
pubmed: 32825578
Cells. 2019 Dec 11;8(12):
pubmed: 31835680
J Mater Chem B. 2020 Sep 14;8(34):7591-7608
pubmed: 32697267
Biomaterials. 2016 Dec;111:55-65
pubmed: 27723556
Int Immunopharmacol. 2020 Jan;78:105985
pubmed: 31776092
Clin Immunol. 2019 Aug;205:116-124
pubmed: 31228581
ACS Nano. 2016 Mar 22;10(3):3323-33
pubmed: 26938862
J Cell Biochem. 2018 Nov;119(11):9433-9443
pubmed: 30074271
FEBS Open Bio. 2020 Oct;10(10):1957-1966
pubmed: 32770719
Theranostics. 2017 Mar 16;7(5):1333-1345
pubmed: 28435469
Int J Pharm. 2020 Jan 5;573:118802
pubmed: 31715354
J Control Release. 2015 Jun 10;207:18-30
pubmed: 25836593
Life Sci. 2020 Oct 15;259:118218
pubmed: 32784057
Pharmaceutics. 2020 Oct 22;12(11):
pubmed: 33105857
Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):E1433-42
pubmed: 25713383
Nucleic Acids Res. 2012 Sep 1;40(17):e130
pubmed: 22618874
J Nephrol. 2020 Aug 16;:
pubmed: 32803682
Int J Clin Exp Pathol. 2019 Jun 01;12(6):2075-2083
pubmed: 31934029
Biochem J. 2018 Nov 28;475(22):3629-3638
pubmed: 30341166
Cell Transplant. 2013;22(12):2279-90
pubmed: 23127285
J Biomed Nanotechnol. 2019 Dec 1;15(12):2401-2412
pubmed: 31748020
AAPS J. 2018 Mar 15;20(3):50
pubmed: 29546642
Biochem Biophys Res Commun. 2020 Jun 18;527(1):153-161
pubmed: 32446360
J Extracell Vesicles. 2014 Feb 17;3:
pubmed: 24624263
Exp Mol Pathol. 2016 Aug;101(1):12-21
pubmed: 27235383
Nucleic Acids Res. 2012 Jan;40(Database issue):D1241-4
pubmed: 21989406
Biochem Biophys Res Commun. 2016 Mar 25;472(1):53-9
pubmed: 26902116
Front Physiol. 2020 May 26;11:441
pubmed: 32528301
J Cell Sci. 2011 Feb 1;124(Pt 3):447-58
pubmed: 21242314
J Exp Clin Cancer Res. 2020 Jan 2;39(1):4
pubmed: 31898515
J Control Release. 2016 Feb 28;224:77-85
pubmed: 26773767
Mol Ther Nucleic Acids. 2020 Sep 4;21:512-522
pubmed: 32682291
Biomaterials. 2021 Jan;264:120369
pubmed: 32977209
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2611-2618
pubmed: 30126637
Arthritis Rheum. 2012 Apr;64(4):1227-36
pubmed: 22238051
Int J Biol Sci. 2020 Jan 1;16(4):620-632
pubmed: 32025210
Cell Cycle. 2018;17(21-22):2411-2422
pubmed: 30324848
J Autoimmun. 2011 May;36(3-4):173-80
pubmed: 21376534
Biochimie. 2020 Oct;177:40-49
pubmed: 32800897
Pharmaceutics. 2020 Oct 26;12(11):
pubmed: 33114492
Arthritis Rheum. 2011 Oct;63(10):3067-77
pubmed: 21702008
Cell Transplant. 2016;25(1):1-15
pubmed: 25975931
Int J Mol Sci. 2020 Feb 18;21(4):
pubmed: 32085620
Hypertension. 2021 Jan;77(1):28-38
pubmed: 33222549
Mol Nutr Food Res. 2015 Sep;59(9):1701-12
pubmed: 26047123
J Immunol Res. 2015;2015:394917
pubmed: 25961059
Eur J Clin Invest. 2018 Dec;48(12):e13010
pubmed: 30062774
Curr Opin Rheumatol. 2017 Mar;29(2):178-186
pubmed: 28118202
Front Immunol. 2019 Jun 06;10:1288
pubmed: 31244839
Int J Cancer. 2020 Sep 15;147(6):1694-1706
pubmed: 32064610
Appl Biochem Biotechnol. 2019 Jan;187(1):352-364
pubmed: 29951961
J Control Release. 2013 Nov 28;172(1):229-238
pubmed: 23994516
Adv Sci (Weinh). 2019 Aug 27;6(20):1900513
pubmed: 31637157
Nat Biotechnol. 2011 Apr;29(4):341-5
pubmed: 21423189
Dis Markers. 2015;2015:613536
pubmed: 26435565
EMBO J. 2007 Oct 3;26(19):4263-72
pubmed: 17805347
Int J Cancer. 2020 Nov 12;:
pubmed: 33180334
Nephrol Dial Transplant. 2015 Mar;30(3):410-22
pubmed: 25488895
Cancer Immunol Res. 2018 Aug;6(8):910-920
pubmed: 29907693
Mol Cell Biochem. 2020 Feb;465(1-2):103-114
pubmed: 31858380
Nanomedicine. 2020 Oct;29:102239
pubmed: 32544449
PLoS Biol. 2012;10(12):e1001450
pubmed: 23271954
PLoS One. 2015 Sep 21;10(9):e0138618
pubmed: 26390437
Nature. 2017 Jun 22;546(7659):498-503
pubmed: 28607485
Nat Commun. 2012;3:1282
pubmed: 23250412
Cell Death Dis. 2019 Nov 18;10(12):869
pubmed: 31740664
ACS Appl Mater Interfaces. 2016 Mar 23;8(11):6790-5
pubmed: 26954538
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
J Biol Chem. 2014 Feb 14;289(7):3869-75
pubmed: 24398677
Curr Pharm Des. 2020;26(42):5488-5502
pubmed: 32445443
J Nanobiotechnology. 2020 Aug 20;18(1):115
pubmed: 32819405
J Am Soc Nephrol. 2013 Feb;24(3):385-92
pubmed: 23274427
Bioeng Transl Med. 2020 Jul 16;5(3):e10172
pubmed: 33005738
Int J Nanomedicine. 2019 Nov 04;14:8627-8645
pubmed: 31806961
Nat Biomed Eng. 2020 Jan;4(1):52-68
pubmed: 31937944
FASEB J. 2018 Aug;32(8):4241-4246
pubmed: 29505299
J Cell Physiol. 2019 Dec;234(12):23736-23749
pubmed: 31180587
Life Sci. 2020 Apr 1;246:117401
pubmed: 32035931
J Biol Chem. 2013 Jun 14;288(24):17713-24
pubmed: 23653359
Nanomedicine (Lond). 2017 Nov;12(21):2653-2675
pubmed: 28960165
J Neuroimmune Pharmacol. 2020 Sep;15(3):390-399
pubmed: 31325121
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Theranostics. 2019 Jan 30;9(4):1015-1028
pubmed: 30867813
Front Immunol. 2020 Apr 03;11:229
pubmed: 32328059
Int J Mol Sci. 2020 Aug 02;21(15):
pubmed: 32748889
Nanomedicine. 2018 Jan;14(1):195-204
pubmed: 28982587
Theranostics. 2017 Jan 1;7(1):180-195
pubmed: 28042326
Cells. 2019 Jul 25;8(8):
pubmed: 31349698
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2653-2658
pubmed: 30093115
J Control Release. 2020 Jan 10;317:273-281
pubmed: 31730913
World J Stem Cells. 2020 Aug 26;12(8):879-896
pubmed: 32952864
Nephrol Dial Transplant. 2015 Sep;30(9):1488-96
pubmed: 26040904
Front Oncol. 2019 Oct 22;9:1076
pubmed: 31696054
ACS Appl Mater Interfaces. 2020 Aug 19;12(33):36938-36947
pubmed: 32814390
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23730-23741
pubmed: 32879009
Rheumatology (Oxford). 2012 Jul;51(7):1145-53
pubmed: 22271756
Front Cell Neurosci. 2019 Sep 03;13:394
pubmed: 31551712
Mol Ther. 2010 Sep;18(9):1606-14
pubmed: 20571541
Nanotechnology. 2020 Nov 27;31(48):485101
pubmed: 32931460
Adv Drug Deliv Rev. 2013 Mar;65(3):336-41
pubmed: 22780955
Kidney Int. 2012 Aug;82(4):412-27
pubmed: 22495296
Int J Mol Sci. 2020 Sep 17;21(18):
pubmed: 32957534
Curr Gene Ther. 2020;20(4):297-312
pubmed: 32938348
BMC Cancer. 2011 Mar 27;11:108
pubmed: 21439085
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Sci Rep. 2015 May 26;5:10112
pubmed: 26011176
Cardiovasc Res. 2020 Feb 1;116(2):353-367
pubmed: 31119268
Cell Transplant. 2013;22(2):369-79
pubmed: 23433427
Int J Mol Sci. 2017 Mar 28;18(4):
pubmed: 28350323
Mol Ther. 2016 Aug;24(7):1290-301
pubmed: 27203438
Clin Proteomics. 2017 Jun 21;14:23
pubmed: 28649187
ACS Nano. 2019 Jun 25;13(6):6670-6688
pubmed: 31117376
Nanomedicine. 2016 Apr;12(3):655-664
pubmed: 26586551
Addict Biol. 2019 Sep;24(5):994-1007
pubmed: 30239077
Sci Rep. 2018 Jan 19;8(1):1171
pubmed: 29352188
Cytotherapy. 2017 Apr;19(4):458-472
pubmed: 28188071
Biomaterials. 2020 Feb;231:119675
pubmed: 31838346
Cell Transplant. 2015;24(12):2615-27
pubmed: 25695896
J Cell Mol Med. 2018 Feb;22(2):728-737
pubmed: 29083099
Mol Cancer. 2017 Oct 13;16(1):159
pubmed: 29029605
Nat Commun. 2016 Jul 22;7:12277
pubmed: 27447450
J Cell Physiol. 2021 Feb;236(2):1529-1544
pubmed: 32749687
Mol Ther Nucleic Acids. 2020 Sep 4;21:1100-1110
pubmed: 32866716
Mol Ther. 2011 Oct;19(10):1769-79
pubmed: 21915101
Pharmaceutics. 2020 May 22;12(5):
pubmed: 32456070
Stem Cells. 2012 Jul;30(7):1556-64
pubmed: 22605481
Acta Pharm Sin B. 2016 Jul;6(4):287-96
pubmed: 27471669
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Theranostics. 2020 Jun 22;10(17):7889-7905
pubmed: 32685027
J Exp Med. 1994 Apr 1;179(4):1317-30
pubmed: 7511686
Biomaterials. 2017 Mar;121:121-129
pubmed: 28086180
Arthritis Rheum. 2012 Mar;64(3):778-87
pubmed: 21968947
Stem Cell Res Ther. 2016 Aug 31;7(1):125
pubmed: 27581859
Stem Cells. 2009 Jun;27(6):1421-32
pubmed: 19489103
Int J Mol Sci. 2020 Mar 04;21(5):
pubmed: 32143311
Sci Rep. 2016 Apr 13;6:24120
pubmed: 27071676
PLoS One. 2012;7(3):e33115
pubmed: 22431999
Mol Cancer Ther. 2019 Dec;18(12):2331-2342
pubmed: 31451563
Stem Cell Res Ther. 2019 Dec 17;10(1):393
pubmed: 31847890
Stem Cells Transl Med. 2017 Mar;6(3):1018-1028
pubmed: 28186708
Nat Protoc. 2012 Dec;7(12):2112-26
pubmed: 23154783
J Neuroinflammation. 2018 Jul 12;15(1):204
pubmed: 30001722
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Mol Ther. 2017 Jul 5;25(7):1665-1675
pubmed: 28284981
Theranostics. 2018 Feb 14;8(7):1869-1878
pubmed: 29556361
Int J Mol Sci. 2019 Jul 14;20(14):
pubmed: 31337116
Front Immunol. 2018 Nov 09;9:2538
pubmed: 30473695
Small GTPases. 2017 Oct 2;8(4):220-232
pubmed: 27494381
Arthritis Res Ther. 2017 Oct 17;19(1):230
pubmed: 29041967
Nat Rev Immunol. 2009 Aug;9(8):581-93
pubmed: 19498381
Sci Rep. 2016 Oct 25;6:36025
pubmed: 27777414
Arthritis Res Ther. 2016 Nov 16;18(1):264
pubmed: 27852323
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
J Control Release. 2016 Sep 28;238:166-175
pubmed: 27475298
Int J Rheum Dis. 2020 Nov 7;:
pubmed: 33159418
Cell Commun Signal. 2013 Nov 18;11:88
pubmed: 24245560
Am J Public Health. 2000 Sep;90(9):1463-6
pubmed: 10983209
Front Immunol. 2017 May 10;8:526
pubmed: 28539924
Biomaterials. 2014 Feb;35(7):2383-90
pubmed: 24345736
Nat Cell Biol. 2019 Jan;21(1):9-17
pubmed: 30602770
EBioMedicine. 2018 Aug;34:231-242
pubmed: 30077720
Front Immunol. 2018 Mar 01;9:322
pubmed: 29545790
Mol Cancer. 2018 Oct 3;17(1):143
pubmed: 30285771
Am J Public Health. 2010 Nov;100(11):2279-87
pubmed: 20864721
Stem Cells Dev. 2013 Mar 1;22(5):772-80
pubmed: 23082760
FEBS Open Bio. 2014 May 09;4:458-67
pubmed: 24918061
Diabetes Metab Syndr Obes. 2020 Apr 22;13:1259-1270
pubmed: 32368119
Nat Nanotechnol. 2018 Jan;13(1):82-89
pubmed: 29230043
J Control Release. 2015 May 10;205:35-44
pubmed: 25483424
J Extracell Vesicles. 2020 Jul 26;9(1):1798606
pubmed: 32944186
Osteoarthritis Cartilage. 2016 Dec;24(12):2135-2140
pubmed: 27390028
Stem Cell Res Ther. 2018 Nov 14;9(1):312
pubmed: 30428931
J Biol Res (Thessalon). 2018 Oct 4;25:16
pubmed: 30306067
Stem Cells Dev. 2014 Jun 1;23(11):1233-44
pubmed: 24367916
Front Cell Dev Biol. 2020 Sep 09;8:698
pubmed: 33015029
Cancer Res. 2011 Aug 1;71(15):5235-44
pubmed: 21670078
EMBO J. 2017 Oct 16;36(20):3012-3028
pubmed: 28923825
Stem Cell Res Ther. 2014 Jan 10;5(1):5
pubmed: 24411922
J Vis Exp. 2018 Dec 5;(142):
pubmed: 30582600
Traffic. 2010 May;11(5):675-87
pubmed: 20136776
Arthritis Res Ther. 2019 Jan 23;21(1):34
pubmed: 30674349
JCI Insight. 2018 May 17;3(10):
pubmed: 29769437
J Extracell Vesicles. 2016 Mar 14;5:31053
pubmed: 26979463
J Clin Invest. 2016 Aug 1;126(8):2805-20
pubmed: 27348586
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
Cell Mol Neurobiol. 2016 Apr;36(3):301-12
pubmed: 27053351
Clin Rheumatol. 2014 Nov;33(11):1611-9
pubmed: 25119864
Eur J Immunol. 2019 Feb;49(2):323-335
pubmed: 30537116
Int J Mol Sci. 2018 Apr 18;19(4):
pubmed: 29670015
Stem Cell Rev Rep. 2020 Sep 15;:
pubmed: 32935222
J Control Release. 2014 Oct 28;192:262-70
pubmed: 25084218
Mol Pharm. 2017 Nov 6;14(11):4079-4086
pubmed: 28977747
Biochim Biophys Acta Gen Subj. 2018 May;1862(5):1091-1100
pubmed: 29410228
Exp Cell Res. 2019 Oct 15;383(2):111541
pubmed: 31369752
Sci Transl Med. 2018 Jun 6;10(444):
pubmed: 29875202
Acta Biomater. 2019 Mar 1;86:480-492
pubmed: 30630122
Dis Markers. 2020 Aug 12;2020:8897833
pubmed: 32849923
Clin Immunol. 2015 Sep;160(1):46-58
pubmed: 25842185
Arthritis Rheumatol. 2016 Feb;68(2):462-72
pubmed: 26360137
Biomaterials. 2018 Feb;156:16-27
pubmed: 29182933
EMBO Mol Med. 2013 Feb;5(2):235-49
pubmed: 23165896
J Neural Transm (Vienna). 2010 Jan;117(1):1-4
pubmed: 19680595
Daru. 2019 Dec;27(2):533-539
pubmed: 31317441
Methods Mol Biol. 2020;2108:181-196
pubmed: 31939181
Mov Disord. 2014 Oct;29(12):1476-85
pubmed: 25112864
Kidney Int. 2017 Jul;92(1):114-124
pubmed: 28242034
J Proteomics. 2010 Sep 10;73(10):1907-20
pubmed: 20601276
J Cell Biochem. 2019 Mar 1;:
pubmed: 30825220
J Immunol. 2018 Oct 15;201(8):2472-2482
pubmed: 30224512
Mol Ther. 2013 Jan;21(1):185-91
pubmed: 23032975
J Am Heart Assoc. 2018 Aug 7;7(15):e008737
pubmed: 30371236
Pharm Res. 2015 Jun;32(6):2003-14
pubmed: 25609010
Biomaterials. 2018 Jan;150:137-149
pubmed: 29040874
Int J Mol Sci. 2020 Jul 05;21(13):
pubmed: 32635660
ACS Nano. 2017 Jan 24;11(1):69-83
pubmed: 28068069
Stem Cell Res Ther. 2018 Sep 26;9(1):247
pubmed: 30257711
Nat Rev Rheumatol. 2016 Nov 22;12(12):716-730
pubmed: 27872476
J Control Release. 2006 Aug 10;114(1):100-9
pubmed: 16831482
Stem Cells Int. 2016;2016:1240301
pubmed: 27843457
Biochem Biophys Res Commun. 2018 May 23;499(4):803-808
pubmed: 29621543
Circ Res. 2015 Jun 19;117(1):7-9
pubmed: 26089361

Auteurs

Ana Ortega (A)

Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.

Olga Martinez-Arroyo (O)

Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.

Maria J Forner (MJ)

Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Internal Medicine Unit, Hospital Clinico Universitario, 46010 Valencia, Spain.

Raquel Cortes (R)

Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.

Classifications MeSH